 This study identified a prognostic risk assessment model for stomach adenocarcinoma, STAD, using an oikis-related long non-coding INA, LNCRNA, genes. The model was proven to have high predictive accuracy and can provide a reference for prognostic evaluation and clinical treatment of STAD patients.